Hot Features
Premium
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Period:
Draw Mode:
| Volume | 480,575 |
|
|||||
| News | - | ||||||
| Day High | 110.8214 | Low High |
|||||
| Day Low | 106.73 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Jazz Pharmaceuticals PLC | JAZZ | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 2.03 | 1.89% | 109.46 | 16:38:25 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 107.00 | 106.73 | 110.8214 | 109.46 | 107.43 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 13,695 | 480,575 | US$ 109.45 | US$ 52,600,621 | - | 106.605 - 146.70 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 16:10:04 | 1 | US$ 105.05 | USD |
Jazz Pharmaceuticals PLC Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 6.83B | 62.35M | - | 3.83B | 414.83M | 6.65 | 16.46 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Jazz Pharmaceuticals News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical JAZZ Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 109.27 | 111.35 | 106.73 | 108.97 | 494,582 | 0.19 | 0.17% |
| 1 Month | 120.58 | 120.81 | 106.605 | 112.20 | 530,989 | -11.12 | -9.22% |
| 3 Months | 122.35 | 134.17 | 106.605 | 119.05 | 606,936 | -12.89 | -10.54% |
| 6 Months | 129.17 | 134.48 | 106.605 | 120.79 | 642,186 | -19.71 | -15.26% |
| 1 Year | 140.71 | 146.70 | 106.605 | 125.95 | 605,540 | -31.25 | -22.21% |
| 3 Years | 167.48 | 189.00 | 106.605 | 141.44 | 591,111 | -58.02 | -34.64% |
| 5 Years | 128.34 | 189.00 | 86.88 | 139.06 | 592,695 | -18.88 | -14.71% |
Jazz Pharmaceuticals Description
| Jazz Pharmaceuticals is an Ireland-domiciled biopharmaceutical firm focused primarily on treatments for sleeping disorders and oncology. Jazz has nine approved drugs across neuroscience and oncology indications; its portfolio includes Xyrem and Xywav for narcolepsy, Zepzelca for the treatment of metastatic small cell lung cancer, Rylaze for acute lymphoblastic leukemia, and Vyxeos for acute myeloid leukemia. In May 2021, Jazz acquired GW Pharmaceuticals and gained its leading product, Epidiolex for the treatment of severe, rare forms of epilepsy. |
